<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    CareTrust REIT, Inc.

    CareTrust REIT, Inc.

    CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investmen...

    CareTrust REIT, Inc. is a self-administered, pu...

    Filing Type:    PU
    Pluton Biosciences, LLC

    Pluton Biosciences, LLC

    Nature is full of untapped potential. Microbes are a proven but underused resource...

    Nature is full of untapped potential. Microbes ...

    Amount Raised:    $98,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    TCR2 Therapeutics Inc.

    TCR2 Therapeutics Inc.

    TCR² is an innovative immunotherapy company developing the next generation of T c...

    TCR² is an innovative immunotherapy company de...

    Filing Type:    PU
    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow is here to change the way we think about artificial limbs. They...

    Unlimited Tomorrow is here to change the way we...

    Amount Raised:    $883,964.00
    Fundraising Status:    EC
    Filing Type:    CF
    Hologic, Inc.

    Hologic, Inc.

    As the leader women’s health, we deliver life-changing and life-saving diagnosti...

    As the leader women’s health, we deliver life...

    Filing Type:    PU
    ConforMIS, Inc.

    ConforMIS, Inc.

    ConforMIS is a medical technology company that uses its proprietary iFitÂŽ Image-t...

    ConforMIS is a medical technology company that ...

    Filing Type:    PU
    Moleculin Biotech, Inc.

    Moleculin Biotech, Inc.

    Moleculin Biotech, Inc. is a clinical stage pharmaceutical company focused on the ...

    Moleculin Biotech, Inc. is a clinical stage pha...

    Filing Type:    PU
    Novelion Therapeutics Inc.

    Novelion Therapeutics Inc.

    Novelion Therapeutics Inc. (“Novelion"), headquartered in Vancouver, British Col...

    Novelion Therapeutics Inc. (“Novelion"), head...

    Filing Type:    PU
    Sunesis Pharmaceuticals, Inc.

    Sunesis Pharmaceuticals, Inc.

    Sunesis is a biopharmaceutical company focused on the development and commercializ...

    Sunesis is a biopharmaceutical company focused ...

    Filing Type:    PU
    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    Kura Oncology, Inc.

    Kura Oncology, Inc.

    We are a clinical-stage biopharmaceutical company committed to realizing the promi...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Delee Corp

    Delee Corp

    At Delee we’re fundamentally changing not only the way cancer is detected but also...

    At Delee we’re fundamentally changing not only ...

    Amount Raised:    $492,503.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.